The Lung Cancer Channel is supported with funding from Johnson & Johnson (Gold) and Takeda (Gold).
VJOncology is an independent medical education platform. Supporters, including channel supporters, have no influence over the production of content. The levels of sponsorship listed are reflective of the amount of funding given to support the channel.
WCLC 2024 | Recommendations for reporting NGS results in NSCLC
Umberto Malapelle, PhD, University of Naples Federico II, Naples, Italy, discusses guidelines on reporting next-generation sequencing (NGS) results for patients with non-small cell lung cancer (NSCLC). Standardization of NGS reporting is needed to accurately analyze genomic and circulating tumor DNA, which will enable efficacious clinical decision-making. This interview took place at the 2024 World Conference on Lung Cancer (WCLC) in San Diego, CA.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.
